Advisory Committees

2010 Meeting Materials, Vaccines and Related Biological Products Advisory Committee

Material is organized by meeting date, with more recent meeting first.

November 16-17, 2010: Vaccines and Related Biological Products Advisory Committee Meeting

On November 16, 2010, the committee will meet in open session to review and discuss the pathway to licensure for protective antigen-based anthrax vaccines for a post-exposure prophylaxis indication using the animal rule. On November 17, 2010, the committee will meet in open session to review and discuss the effectiveness of vaccinating males and females with Gardasil manufactured by Merck

Septmber 21, 2010: Vaccines and Related Biological Products Advisory Committee Meeting

On September 21, 2010, the committee will meet in open session to hear updates on the research programs of the Laboratory of Respiratory

May 7, 2010: Vaccines and Related Biological Products Advisory Committee Meeting

On May 7, 2010, in the morning, the committee will review and discuss available data regarding the unexpected finding of DNA originating from porcine circovirus type 1 (PCV 1) in Rotarix, a U.S. licensed vaccine manufactured by GlaxoSmithKline and indicated for the prevention of rotavirus gastroenteritis in infants.

February 22, 2010: Vaccines and Related Biological Products Advisory Committee Meeting

On February 22, 2010, the committee will discuss and make recommendations on the selection of strains to be included in the influenza virus vaccine for the 2010-2011 influenza season.

Page Last Updated: 08/13/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.